Table 1.
Disease | Year (Ref) | Specific mutation | iPSC-CM in vitro phenotype | Cardiac muscle clinical phenotype |
---|---|---|---|---|
Glycogen Storage disorder | ||||
Pompe Disease (Type II) | 2011 (17) | Unspecified GAA gene mutations | Lysosomal glycogen accumulation; increased autophagosome structures; mitochondrial dysfunction | Hypertrophy, hyperdynamic systolic function with outflow obstruction |
2014 (18) | Compound heterozygote mutations: [del ex18] exon 18 deletion and [del525T] single nucleotide exon 2 deletion in GAA gene Compound heterozygote mutation: (IVS1-13T>G) and deletion of exon 18 in GAA gene |
Elevated lysosomal glycogen; larger glycogen granules observed in infantile compared to late onset PD iPSC-CMs | ||
2015 (19) | Homozygous exon 18 deletion in GAA Heterozygous exon 18 deletion in GAA |
Lysosomal glycogen accumulation; autophagic dysfunction - autophagosome accumulation and higher electrophoretic mobility of lysosome-associated membrane proteins | ||
2015 (20) | Heterozygous mutation c.796C>T and c.1316T>A in GAA | Lysosomal glycogen accumulation | ||
Danon Disease (Type IIb) | 2015 (21) | 2 base pair insertion in exon 2 of LAMP-2 gene (129-130 insAT) Single point mutation in intron 1 of LAMP-2 gene (IVS-1 c.64+1 G>A) |
Increased early autophagic vacuoles, lack of mature autophagic vacuoles; Heart failure feature: cellular hypertrophy; Oxidative stress features: fragmented, short mitochondria, poor mitochondrial network | Hypertrophy, reduced ejection fraction, and altered calcium handling consistent with heart failure |
Mitochondrial disease | ||||
Barth Syndrome | 2011 (22) | Missense mutation in TAZ1 gene (590G>T) Splice site mutation in TAZ1 gene (110-1AG>AC) Missense mutation in TAZ1 (170G>T) |
Impaired cardiolipin remodeling: absent mature CL and accumulation of precursor, MLCL; decreased respiratory chain supercomplex formation; altered mitochondrial oxygen consumption; increased ROS CM differentiation unsuccessful due to cell death |
Dilated cardiomyopathy |
2014 (23) | Frameshift mutation in TAZ gene (c.517delgG) Missense mutation in TAZ gene (c.328T>C) |
Impaired cardiolipin remodeling; lower ATP levels; impaired sarcomerogenesis; defective contractility | ||
Lysosomal storage disease | ||||
Fabry disease | 2013 (24) | Hemizygous mutation in exon 3 of GLA gene c.485G>A | Membranous cytoplasmic bodies in lysosomes CM differentiation unsuccessful due to cell death |
Hypertrophic cardiomyopathy, left ventricular hypertrophy, systolic and diastolic dysfunction, arrhythmias |
2014 (25) | Hemizygous mutation in exon 3 of GLA gene c.485G>A Hemizygous mutation in exon 5 of GLA gene c.658C>T |
Lysosomal globotriaosylceramide accumulation; electron dense storage inclusions (zebra bodies); disorganized contractile fibers with peripheral localization |